Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-25-000538
Filing Date
2025-08-18
Accepted
2025-08-18 12:11:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5007
  Complete submission text file 0000935836-25-000538.txt   6462
Mailing Address 1802 NW WILD RYE CIRCLE BEND OR 97703
Business Address
LYNCH TIMOTHY P (Filed by) CIK: 0001270925 (see all company filings)

Type: SCHEDULE 13G

Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Subject) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90861 | Film No.: 251227032
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)